微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950142-21-000106 Size: 10 KB 网页链接
$Exagen(XGN)$ 内部交易: 2021-01-07,10% Owner,Hunt Holdings Limited Partners ,卖出,10000普通股, $16.04
$Exagen(XGN)$ 内部交易: 2021-01-11,10% Owner,Hunt Holdings Limited Partners ,卖出,7394普通股, $16.03
$Exagen(XGN)$ 内部交易: 2021-01-08,10% Owner,Hunt Holdings Limited Partners ,卖出,15186普通股, $16.07
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950142-21-000066 Size: 13 KB 网页链接
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-21-000004 Act: 34 Size: 78 KB 网页链接
$Exagen(XGN)$ 8-K Current report, item 1.01 Accession Number: 0001274737-20-000103 Act: 34 Size: 25 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-063805 Size: 7 KB 网页链接
$Exagen(XGN)$ 内部交易: 2020-12-15,Director,TULLIS JAMES L L ,卖出,12000普通股, $12.23
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-063548 Size: 7 KB 网页链接